» Articles » PMID: 26113201

A Two-Phase Pathogenetic Model of Depression After Stroke

Overview
Journal Gerontology
Specialty Geriatrics
Date 2015 Jun 27
PMID 26113201
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Depression is among the major long-term complications of cerebral stroke. Occurring in about 30% of all stroke survivors, 'poststroke depression' (PSD) is known to be associated with prolonged recovery, reduced quality of life, and increased mortality. Research over the past 25 years has enlarged our knowledge about organic and psychosocial risk factors, but their interaction is still unclear. In this paper, we start by reviewing and discussing pathogenetic PSD models that were proposed in the 1980s and 1990s. Based on these earlier approaches and on longitudinal research published since that time, a biphasic model is proposed that reflects the current knowledge on the emergence of PSD. The model integrates premorbid, stroke-related and psychosocial risk factors contributing to the emergence of PSD within the first 2 years after stroke. The distinction between 'reactive' and 'organic' PSD has been dropped, and groups of well-documented predictors are recommended for future research. Finally, we will outline possible implications of the model for prevention and therapy.

Citing Articles

Association between atherogenic index of plasma and post-stroke depression: a cross-sectional study.

Kong D, Zou W Eur J Psychotraumatol. 2024; 15(1):2429266.

PMID: 39648850 PMC: 11632925. DOI: 10.1080/20008066.2024.2429266.


A novel approach to treating post-stroke depression: administration of Botulinum Toxin A via local facial injection.

Feng X, Shen T, Wu Q, Wang J, Ni P, Liu J Front Neurol. 2024; 15:1372547.

PMID: 38957350 PMC: 11217355. DOI: 10.3389/fneur.2024.1372547.


Natural history of depression up to 18 years after stroke: a population-based South London Stroke Register study.

Liu L, Marshall I, Pei R, Bhalla A, Wolfe C, Dl OConnell M Lancet Reg Health Eur. 2024; 40:100882.

PMID: 38745986 PMC: 11092885. DOI: 10.1016/j.lanepe.2024.100882.


Integrative-interpersonal dynamic therapy for poststroke depression (INID): study protocol of a randomised controlled pilot trial.

Volz M, Mundiyanapurath S, Schauenburg H, Meuth S, Wild B, Werheid K BMJ Open. 2023; 13(8):e077656.

PMID: 37553187 PMC: 10414082. DOI: 10.1136/bmjopen-2023-077656.


Predictors of post-stroke depression: Validation of established risk factors and introduction of a dynamic perspective in two longitudinal studies.

Ladwig S, Werheid K, Sudmeyer M, Volz M Front Psychiatry. 2023; 14:1093918.

PMID: 36860505 PMC: 9969555. DOI: 10.3389/fpsyt.2023.1093918.